Some breast cancers mayregress spontaneously

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 1
Volume 31
Issue 1

Unexpected findings from a study ofNorwegian women who have and have notreceived routine biennial screening mammographysuggest some breast cancers mayspontaneously regress.

Unexpected findings from a study of Norwegian women who have and have not received routine biennial screening mammography suggest some breast cancers may spontaneously regress.

Dr. Per-Henrik Zahl, a senior statistician at the Norwegian Institute of Public Health in Oslo, and colleagues compared cumulative breast cancer incidence in agematched cohorts of women before and after the initiation of biennial mammography.

The initiation of screening mammography has been associated with increased breast cancer incidence among women of screening age, the researchers said. If all the newly detected cancers progressed and became clinically evident as women age, a fall in incidence among older women should follow, but such was not the case in this study. Results were reported in the Nov. 24 issue of the Archives of Internal Medicine (2008;168[21]:2311-2316).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.